A review of lung-to-blood absorption rates for radon progeny

Parameter uncertainty analysis of the equivalent lung dose coefficient for the intake of radon in mines: A review

Radon presents significant health risks due to its short-lived progeny. The evaluation of the equivalent lung dose coefficient is crucial for assessing the potential health effects of radon exposure. This review focuses on the uncertainty analysis of the parameters associated with the calculation of the equivalent lung dose coefficient attributed to radon inhalation in mines. This analysis is complex due to various factors, such as geological conditions, ventilation rates, and occupational practices. The literature review systematically examines the sources of radon and its health effects among underground miners. It also discusses the human respiratory tract model used to calculate the equivalent lung dose coefficient and the associated parameters leading to uncertainties in the calculated lung dose. Additionally, the review covers the different methodologies employed for uncertainty quantification and their implications on dose assessment. The text discusses challenges and limitations in current research practices and provides recommendations for future studies. Accurate risk assessment and effective safety measures in mining environments require understanding and mitigating parameter uncertainties.

Does protracted radon exposure play a role in the development of dementia?

Radon is a ubiquitous radioactive gas that decays into a series of solid radioactive decay products. Radon, and its decay products, enter the human body primarily through inhalation and can be delivered to various tissues including the brain through systemic circulation. It can also reach the brain by neuronal pathways via the olfactory system. While ionizing radiation has been suggested as a risk factor of dementia for decades, studies exploring the possible role of radon exposure in the development of Alzheimer's Diseases (AD) and other dementias are sparse. We systematically reviewed the literature and found several lines of evidence suggesting that radon decay products (RDPs) disproportionally deposit in the brain of AD patients with selective accumulation within the protein fractions. Ecologic study findings also indicate a significant positive correlation between geographic-level radon distribution and AD mortality in the US. Additionally, pathologic studies of radon shed light on the potential pathways of radon decay product induced proinflammation and oxidative stress that may result in the development of dementia. In summary, there are plausible underlying biological mechanisms linking radon exposure to the risk of dementia. Since randomized clinical trials on radon exposure are not feasible, well-designed individual-level epidemiologic studies are urgently needed to elucidate the possible association between radon (i.e., RDPs) exposure and the onset of dementia.

EFFECTIVE DOSE COEFFICIENTS FOR RADON AND PROGENY: A REVIEW OF ICRP AND UNSCEAR VALUES

The International Commission on Radiological Protection (ICRP) publishes guidance on protection against radon exposure in homes and workplaces. ICRP Publication 137 recommends a dose coefficient of 3 mSv per mJ h m-3 (~10 mSv WLM-1) to be used in most circumstances of radon exposure, for workers in buildings and in underground mines. Recently, United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) reviewed radon epidemiology and dosimetry and concluded that its established dose coefficient of 1.6 mSv per mJ h m-3 (5.7 mSv WLM-1) should be retained for use in its comparisons of radiation exposures from different sources in a population. This paper explains and compares the reviews of the scientific evidence from UNSCEAR and ICRP. It is shown that the UNSCEAR and ICRP reviews are consistent and support the use of the ICRP reference dose coefficients for radiation protection purposes. It is concluded that the ICRP dose coefficient should be used to calculate doses to workers.

Effects of particulate matter gamma radiation on oxidative stress biomarkers in COPD patients

Inhalation of particulate matter (PM) radioactivity is an important pathway of ionizing radiation exposure. We investigated the associations between short-term exposures to PM gamma radioactivity with oxidative stress in COPD patients. Urinary concentrations of 8-hydroxy-2'-deoxyguanosine (8-OHdG) and malondialdehyde (MDA) of 81 COPD patients from Eastern Massachusetts were measured 1-4 times during 2012-2014. Daily ambient and indoor PM gamma activities (gamma-3 through gamma-9) were calculated based on EPA RadNet data and indoor-outdoor infiltration ratios. Linear mixed-effects models were used to examine the associations between biomarkers with PM gamma activities for moving averages from urine collection day to 7 days before. Our results indicate that ambient and indoor PM gamma activities were positively associated with 8-OHdG, with stronger effects for exposure windows closer to urine collection day. For per interquartile range increase in indoor PM gamma activities averaged over urine collection day and 1 day before, 8-OHdG increased from 3.41% (95% CI: -0.88, 7.88) to 8.87% (95% CI: 2.98, 15.1), adjusted for indoor black carbon. For MDA, the timing of greatest effects across the exposure week varied but was nearly all positive. These findings provide insight into the toxigenic properties associated with PM radioactivity and suggest that these exposures promote systemic oxidative stress.

Radiation-related health hazards to uranium miners

Concerns on health effects from uranium (U) mining still represent a major issue of debate. Any typology of active job in U mines is associated with exposure to U and its decay products, such as radon (Rn), thorium (Th), and radium (Ra) and its decay products with alpha-emission and gamma radiation. Health effects in U miners have been investigated in several cohort studies in the USA, Canada, Germany, the Czech Republic, and France. While public opinion is particularly addressed to pay attention to the safety of nuclear facilities, health hazard associated with mining is poorly debated. According to the many findings from cohort studies, the most significant positive dose-response relationship was found between occupational U exposure and lung cancer. Other types of tumors associated with occupational U exposure are leukemia and lymphoid cancers. Furthermore, it was found increased but not statistically significant death risk in U miners due to cancers in the liver, stomach, and kidneys. So far, there has not been found a significant association between U exposure and increased cardiovascular mortality in U miners. This review tries to address the current state of the art of these studies.

ICRP recommendations on radon

The International Commission on Radiological Protection (ICRP) publishes guidance on protection from radon in homes and workplaces, and dose coefficients for use in assessments of exposure for protection purposes. ICRP Publication 126 recommends an upper reference level for exposures in homes and workplaces of 300 Bq m^-3. In general, protection can be optimised using measurements of air concentrations directly, without considering radiation doses. However, dose estimates are required for workers when radon is considered as an occupational exposure (e.g. in mines), and for higher exposures in other workplaces (e.g. offices) when the reference level is exceeded persistently. ICRP Publication 137 recommends a dose coefficient of 3 mSv per mJ h m^-3 (approximately 10 mSv per working level month) for most circumstances of exposure in workplaces, equivalent to 6.7 nSv per Bq h m^-3 using an equilibrium factor of 0.4. Using this dose coefficient, annual exposure of workers to 300 Bq m^-3 corresponds to 4 mSv. For comparison, using the same coefficient for exposures in homes, 300 Bq m^-3 corresponds to 14 mSv. If circumstances of occupational exposure warrant more detailed consideration and reliable alternative data are available, site-specific doses can be assessed using methodology provided in ICRP Publication 137.

Short-term exposure to ambient particle gamma radioactivity is associated with increased risk for all-cause non-accidental and cardiovascular mortality

BACKGROUND

Recent studies have found that particulate matter (PM) attached radioactivity was associated with certain adverse health effects including increased blood pressure and lung dysfunction. However, there has been no investigation on the direct effect of PM radioactivity on mortality.

METHODS

Exposures to ambient PM gamma activities were determined using U.S. EPA RadNet data. Data on daily deaths were obtained from individual state Departments of Public Health. We used a generalized additive quasi-Poisson model to estimate the associations between two-day average ambient PM gamma activities (gamma2 through gamma9) with all-cause non-accidental and cardiovascular daily deaths for each of 18 US cities, for each season, adjusting for two-day average PM_2.5 exposure, temperature, relative humidity, day of week and long-term trends. Subsequently, we used random-effects meta-analysis to estimate the overall effect in the 18 cities for each season.

RESULTS

We found that all-cause non-accidental daily mortality in spring season was positively associated with two-day average ambient PM gamma activities in spring, with significant results for gamma2, gamma5 and gamma6. Similarly, cardiovascular daily mortality was positively associated with two-day average ambient PM gamma activities, with significant results for gamma2, gamma4, gamma5, gamma6, gamma7 and gamma9. For the spring season, each interquartile range (IQR) increase of two-day averaged ambient PM gamma activity was associated with increase in all-cause daily deaths, ranging from 0.15% (95% Confidence Interval (CI): -0.36%, 0.65%) to 1.03 (95%CI: 0.18%, 1.89%). Each IQR was also associated with increase in cardiovascular daily deaths, ranging from 0.01% (95%CI: -0.89, 0.92) to 2.95% (95%CI: 1.33, 4.59). For other seasons overall we found statistically insignificant associations of PM radioactivity with mortality.

CONCLUSIONS

Our findings suggest that there are potential systemic toxic effects of inhalation of radionuclides attached to ambient air particles.

Short-term exposures to particulate matter gamma radiation activities and biomarkers of systemic inflammation and endothelial activation in COPD patients

BACKGROUND

We hypothesized that particulate matter (PM) gamma activity (gamma radiation associated with PM) is associated with systemic effects.

OBJECTIVE

Examine short-term relationships between ambient and indoor exposures to PM gamma activities with systemic inflammation and endothelial activation in chronic obstructive pulmonary disease (COPD) patients.

METHODS

In 85 COPD patients from Eastern Massachusetts, USA from 2012 to 2014, plasma C-reactive protein (CRP), interleukin-6 (IL-6), and soluble vascular cell adhesion molecule-1 (sVCAM-1) were measured seasonally up to four times. We used US EPA RadNet data measuring ambient gamma radiation attached to PM adjusted for background radiation, and estimated in-home gamma radiation exposures using the ratio of in-home-to-ambient sulfur in PM2.5. Linear mixed-effects regression models were used to determine associations between moving averages of PM gamma activities through the week before phlebotomy with these biomarkers. We explored ambient and indoor PM2.5, black carbon (BC), and NO2 as confounders.

RESULTS

Ambient and indoor PM gamma activities measured as energy spectra classes 3 through 9 were positively associated with CRP and IL-6. For example, averaged from phlebotomy day through previous 6 days, each IQR increase in indoor PM gamma activity for each spectra class, was associated with an CRP increase ranging from 7.45% (95%CI: 2.77, 12.4) to 13.4% (95%CI: 5.82, 21.4) and for ambient exposures were associated with an increase of 8.75% (95%CI: -0.57, 18.95) to 14.8% (95%CI: 4.5, 26.0). Indoor exposures were associated with IL-6 increase of 3.56% (95%CI: 0.31, 6.91) to 6.46% (95%CI:1.33, 11.85) and ambient exposures were associated with an increase of 0.03% (95%CI: -6.37, 6.87) to 3.50% (95%CI: -3.15, 10.61). There were no positive associations with sVCAM-1. Sensitivity analyses using two-pollutant models showed similar effects.

CONCLUSIONS

Our results demonstrate that short-term exposures to environmental PM gamma radiation activities were associated with systemic inflammation in COPD patients.

Distribution of radon and risk assessment of its radiation dose in groundwater drinking for village people nearby the W-polymetallic metallogenic district at Dongpo in southern Hunan province, China

Radon in the household water (especially groundwater) which is an important source of indoor radon, has become a potential health hazard to residents. In this study, radon concentrations in groundwater sampled from five villages near Dongpo W-polymetallic metallogenic region were measured using RAD-7 detector with RAD H₂O accessory, and the effect of regional geology and mineralization on radon concentration in groundwater was studied. In addition, we also estimated the radiation doses received by people via ingestion of radon in water and inhalation of the radon from the indoor air while using water. The results show that the radon concentration in groundwater samples varies from 1.29 Bq L^-1 to 31.31 Bq L^-1 with 10.47 Bq L^-1 on average, and about 31.3% of the groundwater samples analyzed have a higher radon concentration than the maximum contaminant level of 11.1 Bq L^-1 recommended by United States Environmental Protection Agency (USEPA). The relatively high radon level in groundwater can be attributed to a relatively high uranium background produced by the magmatic activity and magmatic-hydrothermal system. The values of annual effective dose (AED_ing) due to ingestion of radon in groundwater range from 0.002 mSv y^-1 to 0.055 mSv y^-1, 0.005 mSv y^-1 to 0.11 mSv y^-1 and 0.008 mSv y^-1 to 0.188 mSv y^-1 for adult, child and infant respectively. The values of annual effective dose due to the inhalation of radon released from water are 63.6, 15.4 and 3.8 times of those through the ingestion of radon in groundwater by the adults, children and infants, respectively. In addition, the values of estimated total annual effective doses are 0.020-0.480 mSv y^-1, 0.017-0.406 mSv y^-1 and 0.020-0.484 mSv y^-1 for adult, child and infant, respectively. These values are much lower than the reference dose level of 1 mSv y^-1 recommended by World Health Organization (WHO) and United Nations Scientific Committee on the Effect of Atomic Radiation (UNSCEAR).

Effect modification of ambient particle mortality by radon: A time series analysis in 108 U.S. cities

Numerous studies have reported a positive association between ambient fine particles and daily mortality, but little is known about the particle properties or environmental factors that may contribute to these effects. This study assessed potential modification of radon on PM2.5 (particulate matter with an aerodynamic diameter <2.5 μm)-associated daily mortality in 108 U.S. cities using a two-stage statistical approach. First, city- and season-specific PM2.5 mortality risks were estimated using over-dispersed Poisson regression models. These PM2.5 effect estimates were then regressed against mean city-level residential radon concentrations to estimate overall PM2.5 effects and potential modification by radon. Radon exposure estimates based on measured short-term basement concentrations and modeled long-term living-area concentrations were both assessed. Exposure to PM2.5 was associated with total, cardiovascular, and respiratory mortality in both the spring and the fall. In addition, higher mean city-level radon concentrations increased PM2.5-associated mortality in the spring and fall. For example, a 10 µg/m3 increase in PM2.5 in the spring at the 10th percentile of city-averaged short-term radon concentrations (21.1 Bq/m3) was associated with a 1.92% increase in total mortality (95% CI: 1.29, 2.55), whereas the same PM2.5 exposure at the 90th radon percentile (234.2 Bq/m3) was associated with a 3.73% increase in total mortality (95% CI: 2.87, 4.59). Results were robust to adjustment for spatial confounders, including average planetary boundary height, population age, percent poverty and tobacco use. While additional research is necessary, this study suggests that radon enhances PM2.5 mortality. This is of significant regulatory importance, as effective regulation should consider the increased risk for particle mortality in cities with higher radon levels. Implications: In this large national study, city-averaged indoor radon concentration was a significant effect modifier of PM2.5-associated total, cardiovascular, and respiratory mortality risk in the spring and fall. These results suggest that radon may enhance PM2.5-associated mortality. In addition, local radon concentrations partially explain the significant variability in PM2.5 effect estimates across U.S. cities, noted in this and previous studies. Although the concept of PM as a vector for radon progeny is feasible, additional research is needed on the noncancer health effects of radon and its potential interaction with PM. Future air quality regulations may need to consider the increased risk for particle mortality in cities with higher radon levels.

RADON DOSIMETRY FOR WORKERS: ICRP'S APPROACH

The International Commission on Radiological Protection (ICRP) has recently published two reports on radon exposure; Publication 115 on lung cancer risks from radon and radon progeny and Publication 126 on radiological protection against radon exposure. A specific graded approach for the control of radon in workplaces is recommended where a dose assessment is required in certain situations. In its forthcoming publication on Occupational Intakes of Radionuclides (OIR) document, Part 3, effective dose coefficients for radon and thoron will be provided. These will be calculated using ICRP reference biokinetic and dosimetric models. Sufficient information and dosimetric data will be given so that site-specific dose coefficients can be calculated based on measured aerosol parameter values. However, ICRP will recommend a single dose coefficient of 12 mSv per working level month (WLM) for inhaled radon progeny to be used in most circumstances. This chosen reference value was based on both dosimetry and epidemiological data. In this paper, the application and use of dose coefficients for workplaces are discussed including the reasons for the choice of the reference value. Preliminary results of dose calculations for indoor workplaces and mines are presented. The paper also briefly describes the general approach for the management of radon exposure in workplaces based both on ICRP recommendations and the European directive (2013/59/EURATOM).

The conversion of exposures due to radon into the effective dose: the epidemiological approach

The risks and dose conversion coefficients for residential and occupational exposures due to radon were determined with applying the epidemiological risk models to ICRP representative populations. The dose conversion coefficient for residential radon was estimated with a value of 1.6 mSv year^-1 per 100 Bq m^-3 (3.6 mSv per WLM), which is significantly lower than the corresponding value derived from the biokinetic and dosimetric models. The dose conversion coefficient for occupational exposures with applying the risk models for miners was estimated with a value of 14 mSv per WLM, which is in good accordance with the results of the dosimetric models. To resolve the discrepancy regarding residential radon, the ICRP approaches for the determination of risks and doses were reviewed. It could be shown that ICRP overestimates the risk for lung cancer caused by residential radon. This can be attributed to a wrong population weighting of the radon-induced risks in its epidemiological approach. With the approach in this work, the average risks for lung cancer were determined, taking into account the age-specific risk contributions of all individuals in the population. As a result, a lower risk coefficient for residential radon was obtained. The results from the ICRP biokinetic and dosimetric models for both, the occupationally exposed working age population and the whole population exposed to residential radon, can be brought in better accordance with the corresponding results of the epidemiological approach, if the respective relative radiation detriments and a radiation-weighting factor for alpha particles of about ten are used.

RISKS AND RADIATION DOSES DUE TO RESIDENTIAL RADON IN GERMANY

The population-averaged risk rate and the annual average effective dose due to residential radon in Germany were calculated. The calculations were based on an epidemiological approach taking into account the age- and gender-specific lung cancer incidence rates for the German population and the excess relative risk of 0.16 per 100 Bq·m-3 for residential radon. In addition, the risk estimates adjusted for the smoking habits were determined. The population-averaged risk rate for the whole population was estimated with 4.1·10-5 y-1 (95% confidence interval (CI) 1.4·10-5-7.6·10-5 y-1). Residential radon causes a detriment per year of 3.3·10-5 y-1 (95% CI 1.1·10-5-6.0·10-5 y-1), which corresponds to an annual average effective dose of 0.6 mSv (95% CI 0.2-1.1 mSv). Annually, ~3400 lung cancer incidences are attributed to residential radon. The results from the epidemiological approach exercised in this study are considerably lower than the effective dose, which would be obtained from the dose conversion coefficient calculated using biokinetic and dosimetric models.

Comprehensive survey of household radon gas levels and risk factors in southern Alberta

BACKGROUND

The inhalation of naturally occurring radon (222Rn) gas from indoor air exposes lung tissue to α-particle bombardment, a highly mutagenic form of ionizing radiation that damages DNA and increases the lifetime risk of lung cancer. We analyzed household radon concentrations and risk factors in southern Alberta, including Calgary, the third-largest Canadian metropolis.

METHODS

A total of 2382 residential homes (2018 in Calgary and 364 in surrounding townships) from an area encompassing 82% of the southern Alberta population were tested for radon, per Health Canada guidelines, for at least 90 days (median 103 d) between 2013 and 2016. Participants also provided home metrics (construction year, build type, foundation type, and floor and room of deployment of the radon detector) via an online survey. Homes that were subsequently remediated were retested to determine the efficacy of radon reduction techniques in the region.

RESULTS

The average indoor air radon level was 126 Bq/m3, which equates to an effective absorbed radiation dose of 3.2 mSv/yr. A total of 1135 homes (47.6%) had levels of 100 Bq/m3 or higher, and 295 homes (12.4%) had levels of 200 Bq/m3 or higher; the range was less than 15 Bq/m3 to 3441 Bq/m3. Homes built in 1992 or later had radon levels 31.5% higher, on average, than older homes (mean 142 Bq/m3 v. 108 Bq/m3). For 90 homes with an average radon level of 575 Bq/m3 before mitigation, radon suppression successfully reduced levels to an average of 32.5 Bq/m3.

INTERPRETATION

Our findings show that radon exposure is a genuine public health concern in southern Alberta, suggest that modern building practices are associated with increased indoor air radon accumulation, legitimatize efforts to understand the consequences of radon exposure to the public, and suggest that radon testing and mitigation are likely to be impactful cancer prevention strategies.

Direct total body 214Bi measurements and their implications for radon dose assessment

Direct ²¹⁴Bi bioassays may elucidate some of the uncertainties related to the relationship between the ambient concentration of radon and its short-lived decay products and the corresponding radiation burdens of individual human subjects. Sequential total body ²¹⁴Bi activity measurements were carried out on a group of 67 healthy adult volunteers living in a region with moderate airborne radioactivity and conducting similar daily activities using a whole-body counter equipped with sixteen NaI(Tl) detectors. The total body ²¹⁴Bi activity in the studied subjects was related to gender, fat-free mass and the season of the year. Approximately 95% and 92% of the ²¹⁴Bi activity measured during the cold seasons of the year in men and women, respectively, was attributed to radon progeny inhalation. Following acute exposure to high airborne radioactivity over a short time period, the ²¹⁴Bi enhancement in a volunteer decreased exponentially with time post-exposure, with a half-time of about 40 min. Taking into account the anticipated low ²¹⁴Bi activity in the vast majority of individuals, and the uncertainties in ²¹⁴Bi biodistribution even during counting, accurate measurements can be obtained using high-sensitivity whole-body counters with almost geometrical invariant counting efficiency.

Stochastic rat lung dosimetry for inhaled radon progeny: a surrogate for the human lung for lung cancer risk assessment

Laboratory rats are frequently used in inhalation studies as a surrogate for human exposures. The objective of the present study was therefore to develop a stochastic dosimetry model for inhaled radon progeny in the rat lung, to predict bronchial dose distributions and to compare them with corresponding dose distributions in the human lung. The most significant difference between human and rat lungs is the branching structure of the bronchial tree, which is relatively symmetric in the human lung, but monopodial in the rat lung. Radon progeny aerosol characteristics used in the present study encompass conditions typical for PNNL and COGEMA rat inhalation studies, as well as uranium miners and human indoor exposure conditions. It is shown here that depending on exposure conditions and modeling assumptions, average bronchial doses in the rat lung ranged from 5.4 to 7.3 mGy WLM(-1). If plotted as a function of airway generation, bronchial dose distributions exhibit a significant maximum in large bronchial airways. If, however, plotted as a function of airway diameter, then bronchial doses are much more uniformly distributed throughout the bronchial tree. Comparisons between human and rat exposures indicate that rat bronchial doses are slightly higher than human bronchial doses by about a factor of 1.3, while lung doses, averaged over the bronchial (BB), bronchiolar (bb) and alveolar-interstitial (AI) regions, are higher by about a factor of about 1.6. This supports the current view that the rat lung is indeed an appropriate surrogate for the human lung in case of radon-induced lung cancers. Furthermore, airway diameter seems to be a more appropriate morphometric parameter than airway generations to relate bronchial doses to bronchial carcinomas.

Application of a Monte Carlo lung dosimetry code to the inhalation of thoron progeny

To determine radiation doses incurred by inhaled thoron progeny, the Monte Carlo radon progeny lung dosimetry code IDEAL-DOSE was adapted to the inhalation of thoron progenies, comprising the alpha-emitting nuclides 216Po, 212Bi and 212Po. Dose calculations for defined exposure conditions yielded a dose conversion coefficient (DCC) of 4.6 mSv WLM(-1) or 94.2 nSv (Bq h m(-3))(-1) when compared with a DCC of 3.8 mSv WLM(-1) if based on the International Commission on Radiological Protection Human Respiratory Tract Model. Bronchial doses were computed for different thoron progenies exposure conditions measured in a Bavarian half-timbered house and in a thoron experimental house at the Helmholtz Zentrum München. DCCs ranged from 4.9 to 12.9 mSv WLM(-1), depending on particle size, unattached fraction and fractional activity concentrations. For exposure-specific indoor aerosol parameters, the thoron progeny DCC is smaller than the radon progeny DCC by about a factor of 2.

A revised model for the deposition and clearance of inhaled particles in human extra-thoracic airways

The International Commission on Radiological Protection (ICRP) Task Group that developed the Human Respiratory Tract Model for Radiological Protection (HRTM) identified a lack of published information on aspects of the clearance of inhaled particles deposited in the human nasal passage. Using the results of a recent human volunteer study on the clearance of inhaled particles from the nose, a revised model of clearance from the extra-thoracic (ET) airways has been developed that addresses important issues for which simplifying assumptions had to be made in the ICRP Publication 66 HRTM ET model. This ET clearance model has been adopted by ICRP for inclusion in the revised HRTM. The derivation of the model and parameter values from the experimental data are explained.